Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Analysts at Pivotal Research Group Reiterate their “Buy” rating for USANA (NYSE:USNA) with $95.0 Target

USANA (NYSE:USNA) Rating Kept

Pivotal Research Group currently has a $95.0 TP on the $1.80 billion market cap company or 26.58 % upside potential. In a note sent to investors on Wednesday, 7 February, Usana (NYSE:USNA) Stock had its “Buy” Rating reaffirmed by stock research analysts at Pivotal Research Group.

NYSE:USNA is now trading 5.70% higher at $75.05 as of 4:03 PM New York time. USANA’s stock is 0% in the last 200 days. It has underperformed the S&P 500 Index, which has gained 6.00% in the same time period.

Institutional Ownership

Hays Advisory Llc had the most significant stake with ownership of 51,222 shares as of q2 2015 for 1.18% of the long stock exposure. Capital Impact Advisors Llc is another quite bullish investment manager who is owning 11,454 shares of USANA or 0.68% of their long stock exposure. Also, Clark Estates Inc Ny have 0.53% of their long stock exposure invested in the company for 20,000 shares. The California-based fund Phocas Financial Corp. revealed it had bought a stake worth about 0.38% of the investment manager’s stock portfolio in USANA. The California-based fund Denali Advisors Llc is also positive about the stock, possessing 39,169 shares or 0.33% of their long stock exposure.

USANA (NYSE:USNA) Profile

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other.

USANA (NYSE:USNA) traded up 5.70% on 7 February, hitting $75.05. A total of 286,925 shares of the company’s stock traded hands. This is up from average of 76,577 shares. USANA has a 52 week low of $52.55 and a 52 week high of $79. The company has a market cap of $1.80 billion and a P/E ratio of 29.93.

Get the latest USANA (NYSE:USNA) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Analysts at Pivotal Research Group Reiterate their “Buy” rating for USANA (NYSE:USNA) with $95.0 Target appeared first on Octafinance.



This post first appeared on Octafinance – Financial News, Reports And Intell, please read the originial post: here

Share the post

Analysts at Pivotal Research Group Reiterate their “Buy” rating for USANA (NYSE:USNA) with $95.0 Target

×

Subscribe to Octafinance – Financial News, Reports And Intell

Get updates delivered right to your inbox!

Thank you for your subscription

×